Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/32965
Citations
Scopus Web of ScienceĀ® Altmetric
?
?
Type: Journal article
Title: Late-onset visceral presentation with cardiomyopathy and without neurological symptoms of adult Sanfilippo A syndrome
Author: Van Hove, J.
Wevers, R.
Van Cleemput, J.
Moerman, P.
Sciot, R.
Matthijs, G.
Schollen, E.
de Jonge, J.
Carey, W.
Muller, V.
Nicholls, C.
Perkins, K.
Hopwood, J.
Citation: American Journal of Medical Genetics Part A, 2003; 118A(4):382-387
Publisher: Wiley-Liss
Issue Date: 2003
ISSN: 1552-4825
1552-4833
Statement of
Responsibility: 
Van Hove, Johan L. K. ; Wevers, Ron A. ; Van Cleemput, Johan ; Moerman, Philippe ; Sciot, Raf ; Matthijs, Gert ; Schollen, Els ; De Jong, Jan G. N. ; Carey, William F. ; Muller, Viv ; Nicholls, Cath ; Perkins, Kelly ; Hopwood, John J.
Abstract: Sanfilippo A syndrome, mucopolysaccharidosis type IIIA, is caused by a deficiency of heparan sulphamidase activity, and usually presents in childhood with neurodegeneration leading to death in teenage years. Visceral symptoms are limited to coarsening and diarrhea. We now describe an adult patient who presented with cardiomyopathy. At age 45 years she had hypertension, and the next year she developed a progressively worsening cardiomyopathy with prominent apical hypertrophy and atrial fibrillation. At age 53, she had severe concentric hypertrophic nonobstructive cardiomyopathy in both ventricles. There was no coarsening of features. Neurologic function, skeleton, cornea, liver, and spleen were normal. Percutaneous endomyocardial biopsy showed ballooned cardiomyocytes with storage vacuoles, containing acid mucopolysaccharides. Leucocytes, uterus, and brain biopsy did not show this storage material. There was a slight increase in total urine mucopolysaccharides, with an increased proportion of heparan sulfates. Heparan sulphamidase activity was deficient in leukocytes and heparan sulphamidase protein and activity were reduced in cultured fibroblasts. No mutations were identified after sequencing of the heparan sulphamidase gene at the cDNA and the genomic level. This new clinical presentation expands the clinical spectrum of Sanfilippo A syndrome to include a primary visceral presentation of cardiomyopathy without neurologic symptoms in the adult. The late onset may be related to the residual heparan sulphamidase activity. The genetic basis of this new variant is still unclear. Physicians evaluating adults must remain aware of possible new adult presentations of storage conditions.
Keywords: Fibroblasts
Humans
Cardiomyopathies
Mucopolysaccharidosis III
Hydrolases
Glycosaminoglycans
Heparitin Sulfate
Middle Aged
Female
DOI: 10.1002/ajmg.a.20068
Published version: http://dx.doi.org/10.1002/ajmg.a.20068
Appears in Collections:Aurora harvest
Paediatrics publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.